sur Telomir Pharmaceuticals, Inc
Telomir Pharmaceuticals' Dr. Michael Roizen to Discuss Longevity on Fox Business
This Sunday, September 29, 2024, Telomir Pharmaceuticals will be highlighted on Fox Business Network's "Health Uncensored with Dr. Drew" at 5:30 PM EST. Dr. Michael Roizen, the company's Special Advisor and Emeritus Chief Wellness Officer at Cleveland Clinic, will delve into the science of longevity and the significance of telomeres in the aging process.
During the segment, Dr. Roizen will discuss Telomir-1, a novel molecule aimed at elongating telomere caps to potentially enhance human and canine lifespans. The conversation will focus on how telomeres affect aging and how Telomir-1 aims to address age-related conditions.
Erez Aminov, Telomir's Chairman and CEO, emphasized the company's ongoing research to expedite regulatory applications for Telomir-1 in both veterinary and human medicine. Aminov noted the company's commitment to accelerating clinical trials for what could be a significant breakthrough in longevity science.
The company encourages audiences to tune in and learn more about the future of therapies targeting the aging process.
R. P.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Telomir Pharmaceuticals, Inc